ArticleInternational journal of nanomedicine2025
Multifunctional Poly(Acrylic Acid)-Coated EuBiGd
Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Folic Acid-Conjugated Albumin-Stabilized Gold-Terbium Nanoparticles for SPCCT/MRI Imaging: An in vitro Cellular and Phantom Study.International journal of nanomedicine · 2026Article
- Facile synthesis of polyethylenimine coated BiRSC advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Recently, diagnostic methods based on multimodal and non-invasive imaging, such as MRI and CT scanners, have been developed for accurate cancer diagnosis. A key limitation of these imaging systems is their low contrast. Therefore, developing stable, non-toxic, and efficient multimodal imaging contrast agents is desirable. In this work, we demonstrated the synthesis of a poly(acrylic acid) (PAA) - coated nanoparticles (NPs), PAA@EuBiGd Methods: We synthesized PAA-coated EuBiGd Results: The cell viability study showed that PAA@EuBiGd Conclusion: The new nanocomposite has proven to be an effective trimodal contrast agent with high attenuation in CT, enhanced T1 signal in MRI, and strong red luminescence in FL imaging with promising diagnostic capabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.